Close Menu

NEW YORK – Meridian Bioscience said on Wednesday that it has received $5.5 million from the National Institute of Health's Rapid Acceleration of Diagnostics initiative, along with a grant of undisclosed size from JobsOhio, to expand production capacity of its SARS-CoV-2 PCR test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.